3D Bioprinting Market Revenue to outshine USD 3895.2 million By 2027

Posted On September 14, 2021     

The Global 3D Bioprinting Market revenue is anticipated to grow to around USD 3895.2 million by 2027 with a CAGR of 15.8% during the year 2021-2027 as per the report published by Value Market Research. With increasing adoption in 3D bioprinting in the healthcare, pharmaceutical, and biotechnology market, the bioprinting market will record notable growth over the years. Furthermore, the widespread use of 3D printing in cosmetic operations and new 3D bioprinting inventions are estimated to bolster the 3D Bioprinting market's growth. The increase in public and private financing for bioprinting research has also fueled the market's expansion. Substantial technological developments in the 3D bioprinting space have occurred for a range of medical applications, including skin tissue production, cancer treatments, bone and cartilage formation, and liver modelling, all of which contribute to the market's growth. Meanwhile, factors such as the favourable regulatory environment in rising nations like India, the availability of a significant number of stem cell product pipelines, and the use of regenerative medicine to treat various ailments are likely to boost the 3D Bioprinting market's growth. Nonetheless, issues like scarcity of trained individuals and high development and production costs impede the market's growth. Furthermore, the successful application of 3D bioprinting technology necessitates ongoing process monitoring, which differs between platforms due to uncontrollable process factors and material variances. As a result, this factor is projected to limit market expansion.

3D Bioprinting is a method of additive manufacturing that utilizes 3D printing to manufacture biomedical parts that maximally mimic natural tissue properties. To generate tissue-like structures, 3D Bioprinting uses the layer-by-layer approach to deposit ingredients called bioinks. As a rule of thumb, 3D Bioprinting consists of three stages: pre-, bio- and post-bioprinting. Generally speaking, 3D bioprinting is utilized to create organ and tissue constructions that can be used in medication research and for medical implants' development. It has also begun to print scaffolds that can be utilized for joint and ligament regeneration. Remarkable improvements in the field of tissue engineering have been attributed mainly to 3D bioprinting.

The elaborate study "Global 3D Bioprinting Market Report By Technology (Magnetic Levitation, Inkjet-Based, Syringe-Based, Laser-Based, Others), By Application (Medical, Dental, Biosensors, Consumer/Personal Product Testing, Bioinks, Food And Animal Product) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2021-2027" poses a refreshing view of the market taking into consideration all the aspects affecting the market.

On the basis of technology the market is segmented into Magnetic Levitation, Inkjet-based, Syringe-based, Laser-based, Others. By application the 3d bioprinting market is categorised as Medical (Tissue and Organ Generation, Medical Pills, Prosthetics and implants, Others), Dental, Biosensors, Consumer/Personal Product Testing, Bioinks, Food and Animal Product. The report covers North America (North America, United State and Rest of North America), Europe (United Kingdom, France , Germany, Rest of Europe), Asia Pacific (China, Japan, India, Rest of Asia Pacific), Latin America (Brazil, Rest of Latin America) and Middle East & Africa. The data tables in these chapters give the market estimates on the basis of all the segments.

The Report Segments Global 3D Bioprinting Market -
By Technology

  • Magnetic Levitation
  • Inkjet-based
  • Syringe-based
  • Laser-based
  • Others

 
By Application

  • Medical (Tissue and Organ Generation, Medical Pills, Prosthetics and implants, Others)
  • Dental
  • Biosensors
  • Consumer/Personal Product Testing
  • Bioinks
  • Food and Animal Product

 
By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 
Players Profiled In the Report:
Envisiontec, Inc., Inventia Life Science PTY LTD, Organovo Holdings, Inc., Vivax Bio, LLC, 3D Bioprinting Solutions, Regemat 3D S.L., Poietis, AlleviCyfuse Biomedical K.K., and Cellink Global.

Download the FREE SAMPLE of Global 3D Bioprinting Market Research Report

 
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.

We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.

Contact:
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Maharashtra, INDIA.
Tel: +1-888-294-1147
Email: [email protected]
Website: https://www.valuemarketresearch.com

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Clients

Testimonials